Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, May 25, 2013 - 12:38pm
tags:
Alimera, JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals, Repros Therapeutics
1 Reason to Expect Big Things from West Pharmaceutical Services
Daily Finance
Saturday, May 25, 2013 - 12:37pm
tags:
West Pharmaceutical
Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln
NASDAQ
Saturday, May 25, 2013 - 12:35pm
tags:
Valeant Pharmaceuticals, Bausch & Lomb, M&A
Evoke Pharma has filed for a $24M IPO. The company is a specialty pharmaceutical developer...
Seeking Alpha
Saturday, May 25, 2013 - 12:33pm
tags:
Evoke Pharma, IPOs
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, May 25, 2013 - 12:32pm
tags:
Vivus, Cempra, Corcept Therapeutics
Obamacare Will Bring Drug Industry $35 Billion In Profits Comment Now Follow Comments
Forbes
Saturday, May 25, 2013 - 12:27pm
tags:
Obamacare, health care reform
Pfizer Will Reward Shareholders With Zoetis Spin-Off
Seeking Alpha
Saturday, May 25, 2013 - 12:26pm
tags:
Pfizer, Zoetis
Siga Ruled Liable for Breaking PharmAthene Drug Contract
Bloomberg
Saturday, May 25, 2013 - 12:25pm
tags:
SIGA technologies, PharmAthene, lawsuits
Eli Lilly And Company (LLY): Today's Featured Drugs Laggard
The Street
Saturday, May 25, 2013 - 12:24pm
tags:
Eli Lilly
Actavis says court blocks generic Pulmicort
Yahoo/AP
Saturday, May 25, 2013 - 12:23pm
tags:
Actavis, generics, Pulmicort
Bristol-Myers Squibb (BMY) Shares Cross 3% Yield Mark
Forbes
Saturday, May 25, 2013 - 12:15pm
tags:
Bristol-Myers Squibb
Merck Stock Is a Good Investment (According to Merck)
Motley Fool
Saturday, May 25, 2013 - 12:10pm
tags:
Merck
3 Humongous Health Care Stocks This Week
Motley Fool
Saturday, May 25, 2013 - 11:54am
tags:
MannKind, Vivus, Ariad Pharmaceuticals
Vical Has A Deep Bench And Near-Term Catalysts
Seeking Alpha
Saturday, May 25, 2013 - 11:54am
tags:
Vical, Collategene, TransVax, stem cells, Allovectin
Promising Data on ONCY's Reolysin
Yahoo/Zacks
Saturday, May 25, 2013 - 11:51am
tags:
Oncolytics, Reolysin, melanoma, metastatic melanoma
MannKind shares leap as web site says firm is a ripe takeover target
MarketWatch
Saturday, May 25, 2013 - 11:46am
tags:
MannKind
Royalty Pharma offer for Elan gets little support
Yahoo/AP
Saturday, May 25, 2013 - 11:36am
tags:
Royalty Pharma, Elan
Encouraging News for Peregrine Pharma
Yahoo/Zacks
Saturday, May 25, 2013 - 11:34am
tags:
Peregrine Pharmaceuticals, bavituximab, non-small cell lung cancer, lung cancer
Acadia: Multiple Data Points Suggest Further Upside In The Stock
Seeking Alpha
Saturday, May 25, 2013 - 11:33am
tags:
Acadia
Merck & Co Inc Stock Buy Recommendation Reiterated (MRK)
The Street
Friday, May 24, 2013 - 11:11am
tags:
Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.